Ryan Cynthia
Known title: EVP, CHROCIK: 0001877352
Associated companies
Transaction History
| CI | ▲ Buy | Option Exercise | 434 | $65K | 8/30/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 3,012 | $449K | 8/29/2023 | View on chart |
| CI | ▼ Sell | Open Market | 3,768 | $1.1M | 8/29/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 244 | $71K | 3/1/2023 | View on chart |
| CI | ▼ Sell | Open Market | 803 | $236K | 2/27/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 371 | $109K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,174 | $0 | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 71 | $21K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 1,515 | $0 | 2/22/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 740 | $103K | 12/19/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 3,009 | $419K | 12/16/2022 | View on chart |
| CI | ▼ Sell | Open Market | 3,009 | $987K | 12/16/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 62 | $15K | 3/1/2022 | View on chart |
| CI | ▲ Buy | Grant | 560 | $0 | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 136 | $31K | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 174 | $40K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 1,735 | $0 | 2/23/2022 | View on chart |
| CI | ▼ Sell | Other | 1,531 | $332K | 12/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.